Gunhild Waldemar

3.6k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Gunhild Waldemar is a scholar working on Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Gunhild Waldemar has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Physiology. Recurrent topics in Gunhild Waldemar's work include Dementia and Cognitive Impairment Research (9 papers), Advanced Neuroimaging Techniques and Applications (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Gunhild Waldemar is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Advanced Neuroimaging Techniques and Applications (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Gunhild Waldemar collaborates with scholars based in Denmark, Sweden and Portugal. Gunhild Waldemar's co-authors include Kristian Steen Frederiksen, Leonardo Pantoni, Franz Fazekas, Philip Scheltens, Steen Gregers Hasselbalch, Ana Verdelho, Timo Erkinjuntti, Frederik Barkhof, Bengt Winblad and Hanna Jokinen and has published in prestigious journals such as Stroke, Journal of the American Geriatrics Society and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Gunhild Waldemar

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

2023 75 citations Linus Jönsson, Anders Wimo et al. The Lancet Regional Health - Europe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gunhild Waldemar Denmark	17	442	232	229	220	171	29	1.1k
Yong S. Shim South Korea	21	675 1.5×	257 1.1×	354 1.5×	245 1.1×	82 0.5×	63	1.1k
Raoul P. Kloppenborg Netherlands	13	456 1.0×	301 1.3×	295 1.3×	166 0.8×	208 1.2×	15	1.2k
Lieza G. Exalto Netherlands	14	442 1.0×	235 1.0×	267 1.2×	142 0.6×	170 1.0×	39	987
Pınar Yilmaz Netherlands	16	248 0.6×	136 0.6×	161 0.7×	111 0.5×	136 0.8×	27	823
Sara E. Berman United States	22	470 1.1×	177 0.8×	323 1.4×	216 1.0×	132 0.8×	40	1.3k
Dong Won Yang South Korea	23	845 1.9×	247 1.1×	382 1.7×	288 1.3×	98 0.6×	105	1.6k
Yeonsil Moon South Korea	20	266 0.6×	153 0.7×	265 1.2×	287 1.3×	108 0.6×	71	1.1k
Katherine A. Gifford United States	23	634 1.4×	208 0.9×	331 1.4×	216 1.0×	138 0.8×	87	1.4k
Abda Mahmood United Kingdom	17	310 0.7×	119 0.5×	173 0.8×	228 1.0×	141 0.8×	31	1.1k
Youzhong An China	14	478 1.1×	136 0.6×	347 1.5×	211 1.0×	197 1.2×	34	1.3k

Countries citing papers authored by Gunhild Waldemar

Since Specialization

Citations

This map shows the geographic impact of Gunhild Waldemar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunhild Waldemar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunhild Waldemar more than expected).

Fields of papers citing papers by Gunhild Waldemar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunhild Waldemar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunhild Waldemar. The network helps show where Gunhild Waldemar may publish in the future.

Co-authorship network of co-authors of Gunhild Waldemar

This figure shows the co-authorship network connecting the top 25 collaborators of Gunhild Waldemar. A scholar is included among the top collaborators of Gunhild Waldemar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunhild Waldemar. Gunhild Waldemar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nielsen, T. Rune, Alexandre de Mendonça, Lutz Froelich, et al.. (2024). Assessment of Dementia in Minority Ethnic Groups in Europe: A 14‐Year Follow‐Up Survey. International Journal of Geriatric Psychiatry. 39(12). e70034–e70034. 2 indexed citations

Simonsen, Anja Hviid, Kristian Winge, Lisette Salvesen, et al.. (2024). Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns. Journal of Neuroinflammation. 21(1). 317–317.

Waldemar, Gunhild, et al.. (2024). Diagnostic performance of light reflex pupillometry in Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(3). e12628–e12628. 5 indexed citations

Jönsson, Linus, Anders Wimo, Ron Handels, et al.. (2023). The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. The Lancet Regional Health - Europe. 29. 100657–100657. 75 indexed citations breakdown →

Musaeus, Christian Sandøe, Christer Nilsson, Chris Cooper, et al.. (2021). Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review. Current Alzheimer Research. 18(9). 689–694. 2 indexed citations

Frederiksen, Kristian Steen, Chris Cooper, Giovanni B. Frisoni, et al.. (2020). A European Academy of Neurology guideline on medical management issues in dementia. European Journal of Neurology. 27(10). 1805–1820. 54 indexed citations

Frederiksen, Kristian Steen, T. Rune Nielsen, Bengt Winblad, et al.. (2020). European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment. European Journal of Neurology. 28(7). 2147–2155. 23 indexed citations

Jørgensen, Kasper & Gunhild Waldemar. (2014). [The prevalence of dementia in Denmark].. PubMed. 176(48). 4 indexed citations

Øksnebjerg, Laila & Gunhild Waldemar. (2012). [Efficacy of cognitive stimulation therapy in patients with dementia].. PubMed. 174(50). 3161–4. 1 indexed citations

10.

Jokinen, Hanna, Kristian Steen Frederiksen, Ellen Garde, et al.. (2012). Callosal tissue loss parallels subtle decline in psychomotor speed. A longitudinal quantitative MRI study. The LADIS Study. Neuropsychologia. 50(7). 1650–1655. 15 indexed citations

11.

Frederiksen, Kristian Steen, et al.. (2012). Added Diagnostic Value of 11C-PiB-PET in Memory Clinic Patients with Uncertain Diagnosis. Dementia and Geriatric Cognitive Disorders Extra. 2(1). 610–621. 36 indexed citations

12.

Frederiksen, Kristian Steen, Ellen Garde, Arnold Skimminge, et al.. (2011). Corpus Callosum Tissue Loss and Development of Motor and Global Cognitive Impairment: The LADIS Study. Dementia and Geriatric Cognitive Disorders. 32(4). 279–286. 23 indexed citations

13.

Ropele, Stefan, Alexandra Seewann, Alida A. Gouw, et al.. (2009). Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion‐weighted and magnetization transfer imaging: The LADIS (leukoaraiosis and disability in the elderly) study. Journal of Magnetic Resonance Imaging. 29(2). 268–274. 28 indexed citations

14.

Jokinen, Hanna, Hely Kalska, Raija Ylikoski, et al.. (2009). MRI-Defined Subcortical Ischemic Vascular Disease: Baseline Clinical and Neuropsychological Findings. Cerebrovascular Diseases. 27(4). 336–344. 69 indexed citations

15.

Poggesi, Anna, Giovanni Pracucci, Hugues Chabriat, et al.. (2008). Urinary Complaints in Nondisabled Elderly People with Age‐Related White Matter Changes: The Leukoaraiosis And DISability (LADIS) Study. Journal of the American Geriatrics Society. 56(9). 1638–1643. 67 indexed citations

16.

Ryberg, Charlotte, Egill Rostrup, Karl Sjöstrand, et al.. (2008). White Matter Changes Contribute to Corpus Callosum Atrophy in the Elderly: The LADIS Study. American Journal of Neuroradiology. 29(8). 1498–1504. 42 indexed citations

17.

Hasselbalch, Steen Gregers, Stavros Balogiannis, Miro Denišlič, et al.. (2007). Education and training of European neurologists in dementia. European Journal of Neurology. 14(5). 505–509. 11 indexed citations

18.

Sjöstrand, Karl, Egill Rostrup, Charlotte Ryberg, et al.. (2007). Sparse Decomposition and Modeling of Anatomical Shape Variation. IEEE Transactions on Medical Imaging. 26(12). 1625–1635. 23 indexed citations

19.

Jokinen, Hanna, Charlotte Ryberg, Hely Kalska, et al.. (2006). Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. Journal of Neurology Neurosurgery & Psychiatry. 78(5). 491–496. 88 indexed citations

20.

Winblad, Bengt, Anders Wimo, Knut Engedal, et al.. (2006). 3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy. Dementia and Geriatric Cognitive Disorders. 21(5-6). 353–363. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact